Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Rebif

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Rebif was produced by Merck KGaA.

2015 set to be a transitional year for Merck KGaA's health unit

2015 set to be a transitional year for Merck KGaA's health unit down sales of its injectable multiple sclerosis (MS) drug Rebif (interferon beta-1a). ... Rebif sales fell nearly 16% to 430m as the MS market continues to switch towards oral therapies such as Biogen Idec's Tecfidera (dimethyl glutamate) and Novartis'

Sanofi persuades FDA to back its MS drug Lemtrada

Sanofi persuades FDA to back its MS drug Lemtrada Merck Serono's Rebif (interferon beta-1a). ... Lemtrada demonstrated superior efficacy over Rebif on annualised relapse rates in the two studies which were the basis for approval.”.

FDA approves Biogen Idec's long-acting MS therapy

FDA approves Biogen Idec's long-acting MS therapy The new long-acting formulation will give Biogen Idec a competitive advantage over interferon rivals such as Bayer's Betaferon/Betaseron (interferon beta-1b) and Merck Serono/Pfizer's Rebif (interferon

Rebif hit again as competition bites

Rebif hit again as competition bites Sales of Merck Serono's flagship multiple sclerosis drug Rebif (interferon beta-1a) were once again dragged down by fierce competition in the second quarter of 2014. ... Rebif's figures include negative exchange rate effects, and Merck insists that

Plegridy approval underlines Biogen Idec's dominance in MS

Plegridy approval underlines Biogen Idec's dominance in MS Plegridy's dosing gives Biogen Idec a competitive advantage over Avonex rivals such as Bayer's Betaferon/Betaseron (interferon beta-1b) and Merck Serono/Pfizer's Rebif (interferon beta-1a), and

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics